Navigation Links
Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities
Date:11/3/2008

HAYWARD, Calif., Nov. 3 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that two of its programs (MBX-2982 and MBX-8025) have been recognized in Windhover's "Top 10 most interesting projects available for partnering" in their respective categories. MBX-2982, a potential first-in-class treatment for type 2 diabetes, was recognized in the metabolic category and MBX-8025, a potential treatment for a range of dyslipidemias, was recognized in the cardiovascular category. The selections were made by independent committees assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology and medical device industries.

"We are honored to receive this significant recognition for not one, but two of our current programs. This recognition underscores both MBX-2982's potential to become an important new therapy for type 2 diabetes, and MBX-8025's potential in the treatment of dyslipidemia," said Harold Van Wart, Ph.D., Chief Executive Officer of Metabolex.

The metabolic selection committee was led by Marc Wortman, contributing writer to Windhover's IN VIVO and Start-Up, and Harris Kaplan, President & CEO, and Jun Huangpu, Managing Director, of Healogix, a leading business development strategy consulting firm. The cardiovascular selection committee was led by Ed Saltzman, President, and Michael Rice, Senior Consultant, of Defined Health, a leading business development strategy consulting firm.

Drawing on the analytic resources of these organizations, the selection committees evaluated hundreds of compounds currently in development.

"Selected companies have been screened using a strict set of judging criteria for the Top 10 award and represent what our committees considered the most attractive metabolic and cardiovascular
'/>"/>

SOURCE Metabolex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Metabolex Names Zhao, Martin to Executive Posts
2. Metabolex Appoints Donald Hill as Chief Financial Officer
3. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
5. Maryland Stem Cell Research Commission Recommends 62 Projects for Funding
6. JIC Invests in Three New Alternative Energy Projects
7. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
8. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
9. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
10. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
11. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...new generation of ultrasmall transistors and more ...ed semiconducting nanowires are closer to reality ...e University and the University of California at L...o create nanowires with layers of different materi...which is a critical requirement for making efficie...
(Date:11/25/2009)...5 /PRNewswire/ - Cytochroma today announced the ap...ctors. Dr. Moldt will replace Mr. Ulrik Spork as t... The number of Board members remains unchanged at ... Peter Moldt to the board and look forward to bene...oma continues to make progress in becoming a leadi...
(Date:11/24/2009)...4 IES (Nasdaq: IESC ), ...unications systems and services for the commercial...day that its commercial business group has been aw...ll the electrical systems for the Level 4 bio-safe...my Medical Research Institute of Infectious Diseas...
(Date:11/24/2009)...YKJAVIK, Iceland, November 24 /PRNewswire-FirstCal...announced that it has received notice from,the Nas...mon stock will be,suspended as of November 30, 200...ies and Exchange Commission, which will remove deC...the company files an appeal to the Nasdaq,Listing ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...enter for Molecular,Medicine (CMM) today said it w...nursing mothers for codeine risks cited in a Frida... (FDA). Late Friday, the FDA issued an advisory n...us, side effect in nursing infants whose mothers a...izers of that drug. The FDA,advisory recommended p...
...is, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an orthobiol...letter dated August 15, 2007 from the US Food and ...amily of Products for,marketing in the US as Class...s includes Accell 100, Accell Connexus and,Accell ... that is not,currently marketed. The products are ...
...Join Forces to Promote Early Detection ...YORK and MILTON KEYNES, United Kingdom, Aug. 20 ,I...d Omron Healthcare (UK),Ltd., a wholly owned subsi...eement to strengthen the link between hypertension... pharmacy healthcare markets. The,agreement combin...
Other Biology Technology:Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers 2IsoTis Receives FDA Clearance for Accell Family of Products 2IsoTis Receives FDA Clearance for Accell Family of Products 3IsoTis Receives FDA Clearance for Accell Family of Products 4InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 2InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 3InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 4
(Date:11/23/2009)...ociety says that western lowland gorillas living i...e "mother lode" of more than 125,000 gorillas disc...ed by growing humans activity in the region. , T...s adjacent to the southwest border of Lac Tl Commu...igh densities of the great apes still exist in the...
(Date:11/23/2009)...at a common oral bacterium may exacerbate autoimmu..."Unique Lipids from a Common Human Bacterium Repre...ing Autoimmunity," appears in the December 2009 is...ltiple sclerosis (MS), a disease where the immune ...nearly 1 in 700 people in the United States. Pati...
(Date:11/23/2009)...ble for the H1N1 virus has been sent to vaccinate ...ion marks the first time vaccine has been sent to ...owa State University,s Hank Harris, professor of a...nd has been shipping preventive doses to swine pro...eks., The latest vaccines were shipped to a swin...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2New marker for Alzheimers discovered 57078 1Green tea component may help preserve stored platelets tissues 9919 1Green tea component may help preserve stored platelets tissues 9919 2Green tea component may help preserve stored platelets tissues 9919 3K States plant pathology head named fellow of Phytopathology Society 9917 1K States plant pathology head named fellow of Phytopathology Society 9917 2
...versity reveals that doctors treating life-threate...the wrong dosage of adrenaline (epinephrine) becau... in salt water in glass ampoules which are broken ...aline contained in the ampoule is usually expresse...t water) and a ratio (1 part drug for every 1000 p...
...or patients with hepatitis C, having a low blood p...d with advanced disease. This problem is compounde...r the disease can further reduce platelet numbers ...se patients the treatment they urgently need. Now,...Medicine finds that a new drug, eltrombopag, appea...
...Human Genome Project and other studies linking hum...mous amount of research producing powerful evidenc...ticist Daniel J. Fairbanks explores some of the ma...erson on the planet in RELICS OF EDEN: THE POWERFU...ooks, $24.95). , This book comes at a time when t...
Other Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 3There is powerful evidence of evolution in human DNA 2
Rat IFN-gamma ELISpot Kit from R&D Systems
Chloramphenicol Acetyltransferase Fluorometric (TMR) Assay Kit, FAST CAT from Molecular Probes (Invitrogen)
Amino acid mixture excluding l-[U-14C]methionine from GE Healthcare, formerly Amersham Biosciences
MitoPT-25:MITOCHONDRIAL PERMEABILITY TRANSITION KIT from AbD Serotec
Biology Products: